Information on RAG1

Basic details

Alt. symbols: RNF74 | MGC43321

Approved name: recombination activating 1
Alt. names: recombination activating gene 1 | recombination activating protein 1, RING finger protein 74, V(D)J recombination-activating protein 1

Location: 11p12: 36510372 - 36593156 (+)
Gene type: protein_coding, 6 transcripts.

Scores: LoFtool: 0.156000 | pLI: 0.00189800 | LOEUF: 0.736

HGNC: 9831

NCBI: 5896, RefSeq: NG_007528.1

Ensembl: ENSG00000166349.11

LRG_98 | Status: public

OMIM: 179615

Expression | ProteinAtlas

Normal function

The RAG1 gene encodes the catalytic subunits of the RAG complex. This complex is a tetramer formed by a dimer of RAG1 subunits and two RAG2 subunits. The RAG complex is crucial for the maturation of lymphocytes (B cells and T cells) as it is involved in the rearrangement and recombination of the genes that encode the immunoglobulins and the T cell receptors (V(D)J recombination). This process is important because it generates the diversity of antibodies and receptors that is needed to recognise a wide variety of antigens. These proteins are encoded by genes made of fragments known as variable (V), diversity (D), and joining (J) segments. Specifically, RAG1 binds to conserved recombination signal sequences (RSS) of the DNA and catalyses a double-strand DNA break between the RSS and the adjacent coding segment, during the V(D)J recombination phase. In addition to its endonuclease activity, RAG1 also acts as an E3 ubiquitin-protein ligase that mediates mono-ubiquitination of histone H3, which is required for the joining step of V(D)J recombination. Although RAG2 is not a catalytic component, it is required for all known catalytic activities of the complex. The RAG complex also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and mono-specific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. The introduction of DNA breaks by the RAG complex on one immunoglobulin allele induces ATM-dependent repositioning of the other allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. The RAG1 protein is composed of 1040 amino acids, which are encoded by a single exon, and it is almost twice the size of RAG2. RAG1 has an N-terminal domain that interacts with importin alpha-1, a DNA-binding domain, 2 Zinc-finger domains and several Zinc-binding sites.

Dysfunction and disease

There are more than 70 loss-of-function variants described in RAG1 that cause severe combined immunodeficiency or Omenn syndrome, when both alleles of the gene are affected. Therefore, this condition is inherited in an autosomal recessive manner and is characterized by almost absent protection against bacterial, viral, or fungal infections, and by symptoms of autoimmunity that can be fatal in childhood. Few isolated cases of patients with a phenotype suggestive of common variable immunodeficienc y caused by mutations in RAG1 has also been described (Abraham et al. 2013, Abolhassani et al. 2014). Mutations in the RAG2 gene (which forms the RAG complex with RAG1) cause the same type of severe immunodeficiency as that caused by mutations in RAG1. Additionally, the mouse model of the hypomorphic variant p.Ser723Cys in RAG1 showed that mice homozygous for the mutation had an early lymphopoiesis defect and a reduction in V(D)J recombination, due to a low recombinase activity of Rag1. On the other hand, heterozygotes for the p.Ser723Cys variant exhibited accelerated senescence of the immune system in older age. This accelerated immune dysfunction was also due to a failure of B and T lymphocyte maturation, and to lower levels of V(D)J recombination in thymocytes and bone marrow cells (Giblin et al., 2009). All kinds of pathogenic variants have been described for the gene (point mutations, deletions, insertions) that lead to a loss of function of the protein, either because they affect an important amino acid residue (missense variants) or because a functional protein cannot be synthesized (nonsense or frameshift mutations). Missense mutations affect evolutionarily conserved residues belonging to virtually all known functional domains of the protein. The variants described that affect residues of the N-terminal domain that interact alpha-1 importin (aa. 1-288) are scarce and therefore their pathogenicity is more questionable. [Load More]

[Reviewed by Andrés Caballero-Oteyza on 2020-10-26 11:27:21]

Associated conditions

Acronym Condition's_name MOI Mode_of_actionwww icon OMIM_ID No.cases
SCID9A Severe combined immunodeficiency 9A, T-B- ARdict. icon 601457www icon 13 (12 fams)
OS2 Omenn syndrome 2 ARdict. icon 603554www icon 5 (5 fams)
3777 Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity ARdict. icon 609889www icon 1 (1 fams)
CCHIDG1 Combined cellular and humoral immune defects with granulomas 1 ARdict. icon 233650www icon 1 (1 fams)
SCID10A Severe combined immunodeficiency 10A, T-B+ ARdict. icon Loss of Function - 1 (1 fams)

Please mind that full curation (inclusion of all published patients) of this gene has not been completed yet. It is currently ongoing.

Transcripts of RAG1

Name ENSEMBL_ID LRG_ID CCDS_ID MANE Transcript.type Exons Canonical CDS_length REFSEQ_ID
201 ENST00000299440.6 1 CCDS7902 Select protein_coding 2 Yes 6588 NM_000448
204 ENST00000697713.1 CCDS7902 protein_coding 3 No NM_001377279
205 ENST00000697714.1 CCDS7902 protein_coding 2 No NM_001377280
206 ENST00000697715.1 CCDS7902 protein_coding 5 No NM_001377277,NM_001377278

Published variants

Found 20 variants

Var.name Exon/Intron cDNA_pos. CDS_change Prot.change Var.type Var.class. Patients
K86Vfs*33 EX2 386-387 c.256_257del p.Lys86ValfsTer33 frameshift_variant Pathogenic 1
R142* EX2 554 c.424C>T p.Arg142Ter stop_gained Pathogenic 1
R142Q EX2 555 c.425G>A p.Arg142Gln missense_variant Likely Pathogenic 1
C335R EX2 1133 c.1003T>C p.Cys335Arg missense_variant Likely Pathogenic 1
R396C EX2 1316 c.1186C>T p.Arg396Cys missense_variant Pathogenic 0
Q407H EX2 1351 c.1221G>C p.Gln407His missense_variant Likely Pathogenic 1
E426del EX2 1401-1403 c.1277_1279del p.Glu426del inframe_deletion Likely Pathogenic 1
A444V EX2 1461 c.1331C>T p.Ala444Val missense_variant Pathogenic 4
R449K EX2 1476 c.1346G>A p.Arg449Lys missense_variant Benign 0
A565P EX2 1823 c.1693G>C p.Ala565Pro missense_variant Likely Pathogenic 1
N591Tfs*14 EX2 1894-1895 c.1766_1769dup p.Asn591ThrfsTer14 frameshift_variant Likely Pathogenic 2
K621E EX2 1991 c.1861A>G p.Lys621Glu missense_variant Likely Pathogenic 1
Q812* EX2 2564 c.2434C>T p.Gln812Ter stop_gained Likely Pathogenic 1
RK829-830S* EX2 2617-2618 c.2487_2488delinsTT p.Arg829_Lys830delinsSerTer stop_gained Likely Pathogenic 1
R841W EX2 2651 c.2521C>T p.Arg841Trp missense_variant Likely Pathogenic 1
A857V EX2 2700 c.2570C>T p.Ala857Val missense_variant Likely Pathogenic 2
R973H EX2 3048 c.2918G>A p.Arg973His missense_variant Likely Pathogenic 0
R975Q EX2 3054 c.2924G>A p.Arg975Gln missense_variant Likely Pathogenic 2
K992E EX2 3104 c.2974A>G p.Lys992Glu missense_variant Pathogenic 1
M1006V EX2 3146 c.3016A>G p.Met1006Val missense_variant Benign 0

Please mind that full curation (inclusion of all published variants) of this gene has not been completed yet. It is currently ongoing.

Diagnostic pitfalls & paradigms

Considerations to take into account when analyzing this gene

Year Paradigm ⓘ PMID Notes
- Regions of Homology -
2014Somatic reversion24817258Authors describe the case of a true somatic reversion in an Indian Sikh male infant born to consanguineous parents, who was found to be heterozygous (in whole blood) for the null L411P mutation. Sequencing of buccal swab showed that the mutation was homozygous. Both parents were heterozygous.
2005Somatic reversion15845893multiple second-site mutations
2019Uniparental disomy3150342613-yo boy with bone marrow evidence of MDS who had been suffering from recurrent infections and pancytopenia for a year. He received HSCT from his sister. Genetic analysis showed multiple homozygosity regions, including a region of RAG1 harbouring a pathogenic missense variant, which was heterozygous in his fingernail DNA. The study concludes that his immunodeficiency was secondary to MDS due to somatic acquisition of segmental UPD.
-Cryptic splicing-Unreported or not recorded in our DB.
-Mosaicism-Unreported or not recorded in our DB.
-Incomplete penetrance-Unreported or not recorded in our DB.
-Di-/oligo-genic inheritance-Unreported or not recorded in our DB.

References linked to variants in RAG1

ID Year Title Journal PMID Variants
55 2010 Homeostatic expansion of autoreactive immunoglobulin-secreti... JEM 20547828 2
56 2017 Investigation of Genetic Defects in Severe Combined Immunode... Scan. J. Immunol. 28109013 1
57 2018 Partial RAG deficiency in a patient with varicella infection... JACI 29410113 2
76 2014 A systematic analysis of recombination activity and genotype... JACI 24290284 4
263 2017 Estimated disease incidence of RAG1/2 mutations: A case repo... JACI 27609655 1
264 2006 RAG-dependent primary immunodeficiencies... Hum. Mut. 16960852 1
265 2007 GvHD-associated cytokine polymorphisms do not associate with... Clin. Immunol. 17572155 1
300 2009 Novel presentation of Omenn syndrome in association with ani... JACI 19178939 1
301 2011 IL7R and RAG1/2 genes mutations/polymorphisms in patients SC... IJAAI 21625022 1
302 2018 Prevalence and clinical challenges among adults with primary... JACI 29477728 1
303 2019 Combined immunodeficiency with late-onset progressive hypoga... Front.. Pediatr. 31058115 1
357 2013 Late-onset combined immune deficiency associated to skin gra... Hum. Immunol. 23085344 2
358 2013 Adult-onset manifestation of idiopathic T-cell lymphopenia d... JACI 23122631 1
359 2016 Mutation c.256_257delAA in RAG1 Gene in Polish Children with... AITE 28083621 1
360 2012 Novel mutatons and diverse clinical phenotypes in recombnase... Italian J. Ped. 22424479 1
361 2015 Identification of Patients with RAG Mutations Previously Dia... JoCI 25516070 2
362 1998 Partial V(D)J recombination activity leads to Omenn syndrome... Cell 9630231 1
363 2005 A novel immunodeficiency associated with hypomorphic RAG1 mu... J. Clin. Investig. 16276422 1
365 2000 N-terminal RAG1 frameshift mutations in Omenn's syndrome: In... PNAS 11121059 1
366 2016 Clinical, immunologic, and genetic characteristics of RAG mu... Immunol. Res. 26476733 1
367 2019 Outcomes and Treatment Strategies for Autoimmunity and Hyper... JACI 30877075 1
368 2017 Abnormalities of T-cell receptor repertoire in CD4 + regulat... JACI 28864286 1
369 2017 Natural killer cells from patients with recombinase-activati... Front. Immunol. 28769923 1
865 2015 Mutations in Recombination Activating Gene 1 and 2 in patien... Clin. Immunol. 25869295 4
872 2019 Phenotypical heterogeneity in RAG-deficient patients from a ... Clin. Exp. Immunol. 30307608 12
1112 2022 Integrating Clinics, Laboratory, and Imaging for the Diagnos... Front. Immunol. 35281075 1

Phenotypic & functional assays available?

Find laboratories offering tests

Check